Ionis Pharmaceuticals IONS Increase Decrease In Other Employee Related Liabilities
Increase Decrease In Other Employee Related Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's increase decrease in other employee related liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's increase decrease in other employee related liabilities?
- Ionis Pharmaceuticals (IONS) reported increase decrease in other employee related liabilities of -$80.19M in Q1 2026.
- How has Ionis Pharmaceuticals's increase decrease in other employee related liabilities changed year-over-year?
- Ionis Pharmaceuticals's increase decrease in other employee related liabilities decreased by 86.3% year-over-year, from -$43.04M to -$80.19M.
- What does increase decrease in other employee related liabilities mean?
- The change in the amount the company owes to employees for earned benefits and compensation.
- How do you interpret increase decrease in other employee related liabilities?
- An increase represents a deferral of cash outflows, while a decrease indicates the settlement of employee-related obligations.
- How does increase decrease in other employee related liabilities compare across companies?
- Standard operating liability metric; common in all human-capital-intensive industries.